Home » News » Currently Reading:

Nuance To Acquire QuadraMed’s Quantim HIM Line

September 27, 2012 News 3 Comments

9-27-2012 8-26-30 AM

Nuance Communications announced this morning that it will acquire QuadraMed’s Quantim product line for health information management. Quantim includes applications for coding, compliance, computer-assisted coding, abstracting, clinical documentation integrity, record and document management, and workflow.

HIStalk reported Nuance as the buyer Wednesday on Twitter and on HIStalk following the filing of Federal Trade Commission documents. The announcement was reportedly originally scheduled for October 1, the first day of the AHIMA conference.



HIStalk Featured Sponsors

     

Currently there are "3 comments" on this Article:

  1. Re: QuadraMed Quantim product line to Nuance. It may be the only QM software product that actually works. What happens to the rest of the QM business?

  2. HAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHA

    AHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHA

    Really now, what CAC product, what CDI product. To late to write one now.

    Already a done deal. You lost

Text Ads


RECENT COMMENTS

  1. Giving a patient medications in the ER, having them pop positive on a test, and then withholding further medications because…

  2. Apple legacy? Seems I heard that before. Say around 1997. Jobs put out a 15 min video where a guy…

  3. Cmon, publishing and writing about an Only Fans and TikTok user is tabloid news. Its junk news, not up to…

  4. "Healthcare startup Particle Health has been battling electronic health records giant Epic Systems all year. Now, the startup just raised…

  5. I'd never heard of Healwell before and took a look over their offerings. Has anyone used the products? Beyond the…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.